37 completed, 14 unknown, 7 terminated, 5 recruiting. 17 Not applicable, 10 Phase 2, 6 Phase 1, 6 Phase 4, 4 Phase 3.
Follow Intestinal Diseases, Parasitic: new trials by email Literature Review of Intestinal Diseases, Parasitic trials Research Report on Intestinal Diseases, Parasitic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nitazoxanide for Treatment of Cryptosporidium in Children Nitazoxanide, Placebo - Cryptosporidiosis | Phase 3 | Not yet recruiting | Johns Hopkins Bloomberg School of Public Health | 480 | 2026-12-30 | 2026-09-28 |
| The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children Echinacea Extract - Cryptosporidium Infection | Phase 2 | Recruiting | Al-Azhar University | 60 | 2026-01-18 | 2026-02-05 |
| A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants Cryptosporidiosis | Recruiting | Novartis Pharmaceuticals | 30 | 2026-01-09 | 2026-07-21 | |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults Cryptosporidium parvum oocysts (ABO809), EDI048, Placebo - Cryptosporidiosis | Phase 2 | Recruiting | Novartis Pharmaceuticals | 80 | 2025-12-08 | 2026-08-19 |
| Blastocystis and Cryptosporidium Infection in Colorectal Cancer Patients ELISA / PCR - Blastocystis Infection, Cryptosporidium Infection | Unknown | Assiut University | 54 | 2024-11-01 | 2024-04-23 | |
| Cryptosporidiosis and Enteropathogens in Bangladesh Cryptosporidiosis | Active not recruiting | University of Virginia | 150 | 2024-10-01 | 2025-03-30 | |
| A Comparison of Microscopy and Enzyme Linked Immunosorbent Assay for Diagnosis of Giardia Lamblia in Children, Sohag Giardia Lamblia Infection | Unknown | Sohag University | 94 | 2024-07-01 | 2024-08-01 | |
| Paromomycin or Metronidazole for Symptomatic Dientamoeba Fragilis in Adults Paromomycin - Dientamoeba Fragilis Infection | Not applicable | Recruiting | Sheba Medical Center | 60 | 2024-01-22 | 2025-04-02 |
| Isolation and Characterization of Blastocystis Hominis as Apotential Human Pathogen culture and PCR - Blastocystis Hominis Infections | Unknown | Assiut University | 72 | 2023-12-01 | 2023-04-18 | |
| Efficacy of Calprotectin as A Marker For the Pathogenicity of Blastocystis Infection Fecal Calprotectin ELISA kit - Blastocystis Infections | Unknown | Sohag University | 150 | 2023-03-01 | 2023-02-13 | |
| Molecular Characterization of Blastocystis Isolates From Human by Restriction Fragment Length Polymorphism (RFLP) Analysis RFLP analysis of SSU rRNA - Blastocystis Infections | Unknown | Sohag University | 100 | 2022-11-01 | 2022-10-14 | |
| Evaluation of Feconomics for Diagnosis of Intestinal Parasitic Infections Intestinal Parasitic Infection | Unknown | Sohag University | 100 | 2022-07-01 | 2022-06-28 | |
| Study of Efficacy and Safety of ABO809 in Healthy Participants Cryptosporidium parvum oocysts (ABO809) - Cryptosporidium Infection, Cryptosporidiosis | Phase 1 | Completed | Novartis Pharmaceuticals | 30 | 2022-04-07 | 2024-10-02 |
| Cryptosporidium Species in Sohag Governorate Cryptosporidiosis | Unknown | Sohag University | 200 | 2022-03-01 | 2024-04-17 | |
| Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration moxidectin (8 mg) / albendazole (400 mg), ivermectin (200 µg/kg) / albendazole (400 mg), ALBENDAZOLE 400 Mg ORAL TABLET [ZENTEL] - Trichuriasis, Ascariasis | Phase 2 / Phase 3 | Completed | Jennifer Keiser | 536 | 2021-03-01 | 2024-12-05 |
| Vitamin D Estimation With Giardia Lamblia Infections Giardia Lamblia Infection | Unknown | Sohag University | 192 | 2021-02-17 | 2021-03-03 | |
| Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone 20-hydroxyecdysone Oral, Metronidazole Oral, Placebo Oral - Giardia Lamblia Infection | Phase 2 / Phase 3 | Active not recruiting | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | 200 | 2021-01-01 | 2025-04-04 |
| Cryptosporidium Infection and Human Colorectal Cancer Detection of Cryptosporidium infection - Colonic Neoplasms, Cryptosporidiosis | Unknown | Lille Catholic University | 324 | 2020-06-30 | 2023-11-18 | |
| Treatment of Cryptosporidiosis Nitazoxanide with Lactobacillus Reuteri DSM 17938, Nitazoxanide - Cryptosporidiosis | Not applicable | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 64 | 2020-02-01 | 2023-10-16 |
Showing 20 of 66. Sign in to see all of them.
Cryptosporidiosis (32) · HIV Infections (18) · Diarrhea (15) · Giardiasis (14) · Acquired Immunodeficiency Syndrome (12) · AIDS-Related Opportunistic Infections (8) · Blastocystis Infections (5) · Dysentery, Amebic (4) · Malnutrition (4) · Amebiasis (3) · Colorectal Neoplasms (3) · Dientamoebiasis (3) · Schistosomiasis (3) · Anisakiasis (2)
Digestive System Diseases (66) · Gastrointestinal Diseases (66) · Intestinal Diseases (66) · Infections (65) · Parasitic Diseases (65) · Protozoan Infections (53) · Animal Diseases (33) · Parasitic Diseases, Animal (32) · Protozoan Infections, Animal (32) · Coccidiosis (31) · Immune System Diseases (21) · Pathological Conditions, Signs and Symptoms (21) · Urogenital Diseases (21) · Genital Diseases (20)
nitazoxanide (6) · Metronidazole (5) · Albendazole (3) · Azithromycin (3) · Paromomycin (3) · Sanitation (3) · Hand Disinfection (2) · Interleukin-12 (2) · Nutritional Status (2) · Spiramycin (2) · Surveys and Questionnaires (2) · Water Quality (2) · diclazuril (2) · Auranofin (1) · Clofazimine (1)
National Institute of Allergy and Infectious Diseases (NIAID) (9) · Sohag University (6) · Pfizer (4) · Novartis Pharmaceuticals (3) · Assiut University (2) · International Centre for Diarrhoeal Disease Research, Bangladesh (2) · Janssen, LP (2) · McGill University Health Centre/Research Institute of the McGill University Health Centre (2) · Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan (2) · Rhone-Poulenc Rorer (2) · Romark Laboratories L.C. (2) · University Hospital, Lille (2) · Al-Azhar University (1) · Biomedical Research Center EPLS (1) · Centers for Disease Control and Prevention (1)
United States (18) · Bangladesh (6) · Egypt (3) · France (3) · Kenya (3) · Peru (3) · Israel (2) · Tanzania (2) · Cambodia (1) · Côte d’Ivoire (1) · Denmark (1) · Finland (1) · Indonesia (1) · Malawi (1) · Malaysia (1)
Martin Casapia, MD, MPH (2) · Theresa W Gyorkos, PhD (2) · A. Clinton White (1) · Abdurakhim Toychiev, PhD (1) · Amy Pickering, PhD (1) · Ariel Koren, MD (1) · Arthur White (1) · Bertrand Nunes, MD (1) · Bjarte Stubhaug, PhD (1) · Carey J (1) · Carina Levin, MD (1) · Christine Stewart, PhD (1) · Clair Null, PhD (1)
PMID 23996605, PMID 30624600, PMID 18789466, PMID 20377408, PMID 24647023, PMID 26084556, PMID 26282537, PMID 26426270, PMID 27075905, PMID 28056024, PMID 28980942, PMID 29351649, PMID 29378045, PMID 29396219, PMID 29616235, PMID 29616236, PMID 29637891, PMID 29669039, PMID 29976234, PMID 29976251, PMID 30074085, PMID 30139372, PMID 30220046, PMID 30517728, PMID 30963177, PMID 31050672, PMID 31242190, PMID 32277809, PMID 33407549, PMID 34086447, PMID 34319986, PMID 34494545, PMID 34632308, PMID 34748385, PMID 35939520, PMID 36354034, PMID 37832036, PMID 38378704, PMID 38670986, PMID 40454163, PMID 40488529, PMID 41401135, PMID 41467215, PMID 42201116, PMID 42454929
R01AI041735 (1), R01AI043596 (1), R21HD076216 (1), U01AI167788 (1)